American International Group’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-17,408
Closed -$585K 1224
2024
Q1
$585K Sell
17,408
-155
-0.9% -$4.97K ﹤0.01% 1570
2023
Q4
$567K Sell
17,563
-564
-3% -$15.7K ﹤0.01% 1591
2023
Q3
$594K Buy
18,127
+582
+3% +$20.2K ﹤0.01% 1502
2023
Q2
$617K Buy
17,545
+3,013
+21% +$104K ﹤0.01% 1514
2023
Q1
$474K Buy
14,532
+38
+0.3% +$1.73K ﹤0.01% 1627
2022
Q4
$799K Sell
14,494
-115
-0.8% -$6.32K 0.01% 1330
2022
Q3
$647K Buy
14,609
+638
+5% +$31.1K ﹤0.01% 1421
2022
Q2
$681K Buy
13,971
+822
+6% +$37K ﹤0.01% 1417
2022
Q1
$640K Sell
13,149
-806
-6% -$32.9K ﹤0.01% 1588
2021
Q4
$595K Buy
13,955
+1,721
+14% +$68.6K ﹤0.01% 1703
2021
Q3
$469K Sell
12,234
-291
-2% -$9.37K ﹤0.01% 1894
2021
Q2
$354 Buy
12,525
+8,905
+246% +$267K ﹤0.01% 2149
2021
Q1
$120 Buy
3,620
+10
+0.3% +$351 ﹤0.01% 2620
2020
Q4
$131 Buy
+3,610
New +$146K ﹤0.01% 2514

Other funds holding HRMY

American International Group's HRMY Position: Q2 2024 in Review

American International Group sold out of Harmony Biosciences (HRMY) in Q2 2024, closing a stake of 17,408 shares — an estimated $585K sold.

American International Group first reported a position in HRMY in Q4 2020 and held it in 14 quarters. The position peaked at $799K in Q4 2022. 219 funds tracked by Wall St. Rank hold HRMY as of Q2 2024.

  • American International Group reported no remaining Harmony Biosciences position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 17,408 Harmony Biosciences shares in Q2 2024, an estimated $585K.
  • American International Group first reported a position in Harmony Biosciences in Q4 2020 and held it in 14 quarters.
  • American International Group's Harmony Biosciences position peaked at $799K in Q4 2022.
  • 219 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.